Revelation Biosciences Dividend
Dividend criteriumcontroles 0/6
Revelation Biosciences does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
-400.5%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | -400.5% |
| Toekomstig dividendrendement | n/a |
| Dividendgroei | n/a |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | n/a |
| Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Recent updates
Revelation Biosciences surges 46% on licensing deal with Vanderbilt University
Oct 06Revelation Biosciences GAAP EPS of -$0.12
Aug 15Revelation Biosciences stock slides 47% on pricing $5M securities offering
Jul 26Revelation Biosciences: Therapeutics And Diagnostics For Respiratory Viral Infections
Mar 28Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if REVB's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if REVB's dividend payments have been increasing.
Dividendrendement versus markt
| Revelation Biosciences Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (REVB) | n/a |
| Markt onderkant 25% (US) | 1.5% |
| Markt Top 25% (US) | 4.5% |
| Gemiddelde industrie (Biotechs) | 2.2% |
| Analist prognose (REVB) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate REVB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate REVB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate REVB's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as REVB has not reported any payouts.